Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.17%) 5 336.50 points
Dow Jones Futures
(0.06%) 40 162 points
Nasdaq Futures
(0.28%) 18 687 points
Oil
(-0.45%) $79.70
Gas
(1.41%) $2.66
Gold
(0.64%) $2 432.80
Silver
(1.41%) $31.70
Platinum
(-0.84%) $1 080.80
USD/EUR
(0.09%) $0.921
USD/NOK
(0.04%) $10.68
USD/GBP
(0.06%) $0.788
USD/RUB
(-0.42%) $90.59

Realtime updates for PharmaEngine, Inc. [4162.TWO]

Exchange: TWO Sector: Healthcare Industry: Biotechnology
Last Updated20 May 2024 @ 01:30
25% discount on Stockinvest.us - Use code: Podcast

-1.02% TWD 96.90

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 01:30):

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It is developing ONIVYDE, a proprietary liposome encapsulation of irinotecan, a topoisomerase 1 inhibitor for the treatment of metastatic pancreatic cancer; PEP06, which is in Phase I clinical trial for the treatment of cancer; and PEP07, a Chk1 inhibitor, which is in preclinical development stage to accumulate DNA damage in cells, lead to replication catastrophe, and induce cell apoptosis...

Stats
Today's Volume 802 452
Average Volume 793 745
Market Cap 13.92B
EPS TWD0 ( 2024-04-26 )
Next earnings date ( TWD0.550 ) 2024-07-24
Last Dividend TWD0 ( N/A )
Next Dividend TWD0 ( N/A )
P/E 50.73
ATR14 TWD0.0710 (0.07%)

Volume Correlation

Long: -0.02 (neutral)
Short: 0.41 (neutral)
Signal:(57.673) Neutral

PharmaEngine, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PharmaEngine, Inc. Correlation - Currency/Commodity

The country flag 0.50
( neutral )
The country flag 0.20
( neutral )
The country flag 0.66
( moderate )
The country flag 0.25
( neutral )
The country flag -0.39
( neutral )
The country flag -0.60
( weak negative )

PharmaEngine, Inc. Financials

Annual 2023
Revenue: TWD767.67M
Gross Profit: TWD718.97M (93.66 %)
EPS: TWD1.910
FY 2023
Revenue: TWD767.67M
Gross Profit: TWD718.97M (93.66 %)
EPS: TWD1.910
FY 2022
Revenue: TWD654.38M
Gross Profit: TWD604.68M (92.41 %)
EPS: TWD2.22
FY 2021
Revenue: TWD654.84M
Gross Profit: TWD617.76M (94.34 %)
EPS: TWD2.93

Financial Reports:

No articles found.

PharmaEngine, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

PharmaEngine, Inc.

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It is developing ONIVYDE, a proprietary liposome encapsulation of irinotecan, a topoisomerase 1 inhibitor for the treatment of metastatic pancreatic cancer; PEP06, which is in Phase I clinical trial for the treatment of cancer; and PEP07, a Chk1 inhibitor, which is in preclinical development stage to accumulate DNA damage in cells, lead to replication catastrophe, and induce cell apoptosis. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators